PCOS to PMOS
Context:
Polycystic Ovary Syndrome (PCOS) has been officially renamed as Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a global medical consensus published in The Lancet.
The earlier term “PCOS” was medically misleading because many women with the condition do not actually have ovarian cysts.
The change aims to better reflect the condition’s complex hormonal, metabolic, reproductive, and psychological impacts.
About PMOS
PMOS stands for Polyendocrine Metabolic Ovarian Syndrome.
The new terminology highlights that the disorder affects multiple hormonal and metabolic systems rather than only the ovaries.
The term “polyendocrine” reflects the involvement of several hormonal systems, including reproductive hormones, insulin regulation, and adrenal hormones.
The term “metabolic” highlights the strong association of the condition with insulin resistance, obesity, type-2 diabetes, cardiovascular risks, and metabolic syndrome.
Symptoms and Health Risks
PMOS can manifest through irregular menstrual cycles, acne, weight gain, excess facial hair, infertility, and hormonal imbalance.
The condition is also associated with long-term risks such as:
Type-2 diabetes,
Cardiovascular diseases,
Fatty liver disease,
Mental health disorders,
infertility.